Page last updated: 2024-11-01

omeprazole and Leukemia, Pre-B-Cell

omeprazole has been researched along with Leukemia, Pre-B-Cell in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Milito, A1
Iessi, E1
Logozzi, M1
Lozupone, F1
Spada, M1
Marino, ML1
Federici, C1
Perdicchio, M1
Matarrese, P1
Lugini, L1
Nilsson, A1
Fais, S1

Other Studies

1 other study available for omeprazole and Leukemia, Pre-B-Cell

ArticleYear
Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species.
    Cancer research, 2007, Jun-01, Volume: 67, Issue:11

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase Inhibitors; Caspases; Cell Growth Pro

2007